ERDF — INSERM — Support to research projects — Project “Immunotherapy targeting tPA/NMDA receptor interaction for the treatment of central nervous system pathologies” (Invest) (Q3673447)

From EU Knowledge Graph
Revision as of 23:58, 13 January 2022 by DG Regio (talk | contribs) (‎Changed label, description and/or aliases in es: Adding Spanish translations)
Jump to navigation Jump to search
Project Q3673447 in France
Language Label Description Also known as
English
ERDF — INSERM — Support to research projects — Project “Immunotherapy targeting tPA/NMDA receptor interaction for the treatment of central nervous system pathologies” (Invest)
Project Q3673447 in France

    Statements

    country
    France
    0 references
    EU contribution
    23,500.00 Euro
    0 references
    budget
    47,000.0 Euro
    0 references
    co-financing rate
    50.0 percent
    0 references
    start time
    1 September 2014
    0 references
    end time
    28 February 2019
    0 references
    beneficiary name (string)
    EPA INSERM INSTITUT NAT DE LA SANTE ET DE LA RECHERCHE MEDICALE
    0 references
    beneficiary
    Q3764450
    0 references
    postal code
    75654
    0 references

    Identifiers

    French Kohesio ID
    15P05051
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q3673447&oldid=22281474"